Free Trial

Colgate-Palmolive Company (NYSE:CL) Shares Sold by Dynamic Advisor Solutions LLC

Colgate-Palmolive logo with Consumer Staples background

Dynamic Advisor Solutions LLC lessened its position in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 35.8% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 7,215 shares of the company's stock after selling 4,016 shares during the period. Dynamic Advisor Solutions LLC's holdings in Colgate-Palmolive were worth $676,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of the company. Hennessy Advisors Inc. bought a new position in Colgate-Palmolive during the 1st quarter worth approximately $5,781,000. Wealth Enhancement Advisory Services LLC lifted its holdings in shares of Colgate-Palmolive by 23.8% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 329,826 shares of the company's stock worth $30,905,000 after purchasing an additional 63,419 shares during the last quarter. Tritonpoint Wealth LLC lifted its holdings in shares of Colgate-Palmolive by 0.8% in the 1st quarter. Tritonpoint Wealth LLC now owns 58,852 shares of the company's stock worth $5,514,000 after purchasing an additional 485 shares during the last quarter. Griffin Asset Management Inc. lifted its holdings in shares of Colgate-Palmolive by 0.9% in the 1st quarter. Griffin Asset Management Inc. now owns 17,575 shares of the company's stock worth $1,647,000 after purchasing an additional 154 shares during the last quarter. Finally, Azzad Asset Management Inc. ADV bought a new stake in shares of Colgate-Palmolive in the 1st quarter worth approximately $3,992,000. Institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Price Performance

Shares of CL traded down $0.34 during midday trading on Friday, reaching $87.85. The stock had a trading volume of 9,572,245 shares, compared to its average volume of 4,787,812. Colgate-Palmolive Company has a 52 week low of $85.32 and a 52 week high of $109.30. The company has a debt-to-equity ratio of 8.96, a current ratio of 0.85 and a quick ratio of 0.54. The firm's 50 day moving average price is $91.50 and its 200-day moving average price is $90.78. The company has a market capitalization of $71.19 billion, a P/E ratio of 24.82, a P/E/G ratio of 4.66 and a beta of 0.38.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its quarterly earnings data on Friday, April 25th. The company reported $0.91 EPS for the quarter, topping analysts' consensus estimates of $0.86 by $0.05. Colgate-Palmolive had a return on equity of 461.04% and a net margin of 14.52%. The company had revenue of $4.91 billion for the quarter, compared to the consensus estimate of $4.92 billion. During the same quarter in the previous year, the business earned $0.86 EPS. The company's quarterly revenue was down 3.0% compared to the same quarter last year. On average, analysts forecast that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 15th. Stockholders of record on Friday, July 18th will be paid a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.37%. The ex-dividend date is Friday, July 18th. Colgate-Palmolive's dividend payout ratio is presently 58.76%.

Colgate-Palmolive announced that its board has approved a share buyback program on Thursday, March 20th that permits the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization permits the company to reacquire up to 6.8% of its shares through open market purchases. Shares repurchase programs are generally a sign that the company's board believes its shares are undervalued.

Analysts Set New Price Targets

Several brokerages recently issued reports on CL. UBS Group raised their price target on Colgate-Palmolive from $105.00 to $109.00 and gave the stock a "buy" rating in a report on Thursday, April 17th. Wells Fargo & Company raised their price target on Colgate-Palmolive from $83.00 to $88.00 and gave the stock an "underweight" rating in a report on Wednesday, April 2nd. Wall Street Zen downgraded Colgate-Palmolive from a "buy" rating to a "hold" rating in a report on Wednesday, May 7th. JPMorgan Chase & Co. raised their price target on Colgate-Palmolive from $95.00 to $103.00 and gave the stock an "overweight" rating in a report on Monday, April 28th. Finally, Citigroup raised their price target on Colgate-Palmolive from $103.00 to $108.00 and gave the stock a "buy" rating in a report on Monday, April 28th. One analyst has rated the stock with a sell rating, ten have issued a hold rating and ten have assigned a buy rating to the stock. According to data from MarketBeat.com, Colgate-Palmolive presently has an average rating of "Hold" and an average target price of $102.12.

Read Our Latest Research Report on CL

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Recommended Stories

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Should You Invest $1,000 in Colgate-Palmolive Right Now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Time to Cash Out? 5 Stocks to Drop Before Earnings
Watch Before Monday: Stocks to Load Up on Before Earnings
3 Hot Growth Stocks to Watch Right Now!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines